Organs On Chips Market Size, Share, Industry Trends and Forecast to 2030

1. What is the Market Size & CAGR of Organs On Chips market in 2021?

The global organs on chips market is projected to reach a market size of USD 45.2 million in 2021. It is estimated to grow at a compound annual growth rate (CAGR) of 23.6% from 2021 to 2026. The increasing focus on developing alternative methods for drug testing and disease modeling is driving the growth of the organs on chips market.

2. COVID-19 Impact on the Organs On Chips Market

The COVID-19 pandemic has significantly impacted the organs on chips market. During the pandemic, there was a shift towards more in vitro models for drug testing due to the restrictions on in vivo experiments. This has led to increased adoption of organs on chips technology for drug development and toxicology studies. The market witnessed a surge in demand as pharmaceutical companies and research institutions looked for alternative testing methods.

3. Organs On Chips Dynamics

The organs on chips market is driven by factors such as the need for more physiologically relevant models for drug testing, advancements in microfluidics technology, and increasing investments in organ-on-chip research. The ability of organs on chips to mimic the complex structure and function of human organs is a key factor driving their adoption in drug development and personalized medicine.

4. Segments and Related Analysis

The organs on chips market can be segmented based on the type of organ, application, and end-user. Liver-on-a-chip, lung-on-a-chip, heart-on-a-chip, and other organ types are the key segments in the market. Applications of organs on chips include drug screening, toxicity testing, personalized medicine, and others. Pharmaceutical companies, research institutes, and academic laboratories are the primary end-users of organs on chips technology.

5. By Region Analysis

The organs on chips market is analyzed across regions such as North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America dominated the market in 2021 due to the presence of leading pharmaceutical companies, research institutions, and government initiatives promoting organ-on-chip research. However, the Asia Pacific region is expected to witness the highest growth rate during the forecast period.

6. Key Market Players and Competitive Landscape

Key players in the organs on chips market include Emulate Inc., AxoSim Technologies, MIMETAS, TissUse GmbH, and others. These companies are focusing on strategic partnerships, product launches, and acquisitions to strengthen their market position. The competitive landscape of the organs on chips market is rapidly evolving with advancements in technology and growing investments in organ-on-chip research.

7. Recent happenings in the Organs On Chips Market

In recent developments, Emulate Inc. launched a new liver-on-a-chip platform for drug metabolism studies. AxoSim Technologies collaborated with a leading pharmaceutical company to develop a novel nerve-on-a-chip model for drug testing. These advancements highlight the growing importance of organs on chips technology in the field of drug discovery and toxicology.